As on November 24, 2020, BioNTech SE (NASDAQ: BNTX) started slowly as it slid -4.35% to $101.87. During the day, the stock rose to $103.43 and sunk to $97.5601 before settling in for the price of $106.50 at the close. Taking a more long-term approach, BNTX posted a 52-week range of $20.38-$115.00.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -300.50%. This publicly-traded company’s shares outstanding now amounts to $238.67 million, simultaneously with a float of $223.06 million. The organization now has a market capitalization sitting at $22.37 billion. At the time of writing, stock’s 50-day Moving Average stood at $85.67, while the 200-day Moving Average is $63.57.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 1800 workers. It has generated 92,777 per worker during the last fiscal year. Meanwhile, its income per employee was -152,983. The stock had 4.40 Receivables turnover and 0.15 Total Asset turnover. For the Profitability, stocks gross margin was +54.15, operating margin was -169.03 and Pretax Margin of -165.25.
BioNTech SE (BNTX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. BioNTech SE’s current insider ownership accounts for 1.18%, in contrast to 10.40% institutional ownership.
BioNTech SE (BNTX) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2020, the company posted -$1.04 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.44) by -$0.6. This company achieved a net margin of -164.89 while generating a return on equity of -46.70. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.97 per share during the current fiscal year.
BioNTech SE’s EPS decrease for this current 12-month fiscal period is -300.50% and is forecasted to reach 17.78 in the upcoming year.
BioNTech SE (NASDAQ: BNTX) Trading Performance Indicators
Let’s observe the current performance indicators for BioNTech SE (BNTX). It’s Quick Ratio in the last reported quarter now stands at 4.00. The Stock has managed to achieve an average true range (ATR) of 7.26.
Technical Analysis of BioNTech SE (BNTX)
Through scrutinizing the latest numbers posted by the [BioNTech SE, BNTX], it can be observed that its last 5-days Average volume of 5.0 million was better the volume of 2.15 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 69.05% While, its Average True Range was 7.63.
Raw Stochastic average of BioNTech SE (BNTX) in the period of the previous 100 days is set at 78.44%, which indicates a major rise in contrast to 53.69% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 111.17% that was higher than 80.57% volatility it exhibited in the past 100-days period.